Congenital Midline Spinal Hamartoma in a 5-Month-Old Infant

Elric Brahm Malelak1, Christopher Lauren1, Donny Argie1

  • 1Department of Neurosurgery, Prof. Dr. W. Z. Johannes Kupang Regional General Hospital, Kupang, East Nusa Tenggara, Indonesia.

World Neurosurgery
|September 19, 2020
PubMed

Insights

Congenital midline spinal hamartoma is a rare pediatric tumor. Surgical removal is effective for this benign growth, often associated with spinal dysraphism, with good patient outcomes.

Area of Science:

  • Pediatric Neurosurgery
  • Developmental Biology
  • Skeletal Biology

Background:

  • Congenital midline spinal hamartoma is an exceptionally rare tumor-like proliferation primarily affecting children.
  • This condition involves mature ectodermal and mesodermal elements in an aberrant location, frequently linked to neurofibromatosis type 1 and spinal dysraphism.

Observation:

  • A 5-month-old infant presented with a congenital lower back mass, a subcutaneous lesion with a skin dimple.
  • Imaging revealed a dural mass and closed spinal dysraphism from L3 to the sacrum.
  • Histopathology confirmed a hamartoma composed of fat, cartilage, muscle, nerve, and vascular tissue.

Findings:

  • Surgical subtotal resection was performed on the pediatric patient.
  • Post-operative follow-up at 6 months showed no recurrence, neurological deficits, or further growth.
  • Histopathological analysis confirmed the benign nature of the hamartoma.

Implications:

  • Congenital midline spinal hamartoma requires definitive diagnosis via biopsy to differentiate from other spinal anomalies.
  • Surgical excision is the primary treatment, crucial for cosmetic improvement and preventing neurological compromise.
  • Early diagnosis and intervention can lead to favorable outcomes, as demonstrated by the patient's successful recovery.
Abstract